Cancel

Hematologic Malignancies Demystified - Atlanta A Critical Appraisal of Data from 2018

Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data.
This activity is provided by The University of Texas MD Anderson Cancer Center and prIME Oncology.

Hematologic Malignancies Demystified - Houston A Critical Appraisal of Data from 2018

Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data.
This activity is provided by The University of Texas MD Anderson Cancer Center and prIME Oncology.

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

STATEMENT OF NEED Carcinoid syndrome refers to a constellation of symptoms caused by the systemic release of humoral factors such as polypeptides, biogenic amines, and prostaglandins, mostly from well-differentiated neuroendocrine tumors. Patients frequently experience flushing, abdominal cramps, bronchospasms, hypotension, and diarrhea, which lead to impaired quality of life and daily functioning. In addition, complications such as carcinoid heart disease and mesenteric and/or retroperiton...
Postgraduate Institute for Medicine and i3 Health

ASCCP2019 Annual Meeting

ASCCP2019 Annual Scientific Meeting on Anogenital and HPV-Related Diseases will feature a variety of topics including: Barriers to Care (transgender, homeless, incarcerated, mentally ill, as well as age and obesity) Patient-Centered Counseling Techniques for Discussing Risk and Disease State Concepts Research Ethics and At-Risk Populations Cervical Cancer Screening Guidelines – U.S. and Beyond ASCCP Colposcopy Standards with Cases Risk-Based Assessment and Management As well as spec...
ASCCP

Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung cancer will occur in the United States in 2018, resulting in 155,870 deaths. Mesothelioma, a cancer that can develop in the lining of the lungs, is commonly caused by exposure to asbestos and is associated with a poor prognosis. Advances in lung cancer treatment, including the introduction of immune checkpoint inhibitors, are increasing the number of patients who receive treatment ...
Slack Inc.

Breast Ultrasound with Tom Stavros: Hot Topics in Advanced Screening and Diagnosis

Welcome to San Antonio and Hot Topics in Advanced Screening and Diagnosis. This course will emphasize a new classification system on breast cancer and will focus on “non”-mass ultrasound findings, an analysis of causes of false negative BI-RADS 3 classifications, and new ways of classifying breast nodules that can help objectively assign BI-RADS 4 subcategories and improve ultrasound’s ability to serve as a bio-marker. Dr. Stavros will lead interactive case readings with an audience re...
World Class CME

Self-Care Specialist (SCS) Unit 4: Women's Health

Women are generally not too shy in asking questions in the "Feminine Hygiene" aisle. They are very proactive about their health and given a private area, they will specifically tell you what symptoms they are having. This activity is an overview to women's most frequent health issues, including vaginal infections, urinary tract infections and menstrual maladies. We will discuss the number of sexual lubricants that are available and select the right ones be it for a woman wanting to conceive or...
freeCE.com

Payment Models and Practice Changes: Meeting Requirements of OCM & MACRA

Recent legislation and policy has fast-tracked the shift of healthcare payment from volume- to value-based reimbursement under the Medicare Access and CHIP Reauthorization Act (MACRA) for oncology care. Today, oncologists have the option to be reimbursed for Medicare patients under the CMS Oncology Care Model (OCM), an alternative payment model spanning a 6-month chemotherapy episode-of-care. This activity will provide insight into the program’s structure and challenges. It will also review ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care

Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit. Le...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Integrating Immunotherapy for NSCLC

The emergence of checkpoint inhibitors (CTLA4, PD1, PD-L1) has reawakened an interest in immunotherapy to treat various malignancies. New agents have rapidly been approved for use in melanoma, bladder cancer, renal cell, lung cancer, and other malignancies. These agents have a unique toxicity profile requiring careful clinical assessment, rapid intervention, and aggressive management of side effects. This activity will provide a general overview of immunotherapy in cancer treatment, with a ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, Rockpoointe Oncology

Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates

Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to 25% of adenomas are missed with current colonoscopy technologies, primarily due to poor visualization in folds and other difficult-to-detect areas. Technological advances in recent years have improved detection rates. This CME activity will review appropriate screening and prevention efforts for the early detection of patients ...
Slack Inc.

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that colorectal cancers with mismatch repair deficiency (dMMR) and other advanced dMMR cancers are sensitive to immune checkpoint blockade with PD-1 antibodies, and that mutational burden correlates with treatment response. These findings have led to the recent approval of two immune checkpoint inhibitors for the treatment of micro...
Slack Inc.

Navigating New Options to Improve Outcomes in Multiple Myeloma

As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeted Therapy for Skin Malignancies: Basal Cell Carcinoma, Melanoma, and Merkel Cell

Patients may not always be offered the most appropriate single and combination targeted therapies that have been proven effective in clinical trials. Currently available clinical data have practice-changing implications for medical oncologists, dermatologists, and related specialists treating skin malignancies. To stay up to date with the latest data, evidence will be presented related to the role of BRAF inhibition, hedgehog signaling, and immunotherapy in the pathogenesis and treatment of ba...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Updates in General Internal Medicine for Specialists 2019

Advances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists In this special program, Harvard Medical School's leading clinical faculty, representing more than 30 fields of medicine, share updates and provide recommendations to ensure you are current with the recent advances in general internal medicine that impact the specialists—especially with clinical practice in relevant disciplines outside of your field of expertise. Whether you are a psy...
Harvard Medical School Global and Continuing Education

Advances in Breast Cancer Management 2019

This course will provide an overview of the most recent advances in the management of patients with early and advanced stage breast cancer. Topics include imaging, radiation therapy, brain metastases, genomic testing, systemic therapy and survivorship. The course is intended to provide practical, evidence-based information on clinically relevant issues for physicians and allied health personnel involved in patient care. The didactic format will provide significant opportunities for interaction...
Mayo Clinic

The Oncologist: The Challenges of Validating in Precision Medicine: The Case of ERCC1 Diagnostic Testing

Learning Objectives: 1. Describe the obstacles to the successful translation of predictive/prognostic molecular cancer biomarkers to the clinic. 2. Explain the importance of prospective design and good study reporting in predictive/prognostic cancer marker development. 3. Discuss the way poor study design and coordination can impede rapid biomarker validation in cancer. Personalized medicine relies upon the successful identification and translation of predictive biomarkers. Unfortunately...
Society For Translational Oncology

The Oncologist: Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?—Time to Embrace a New Digit

Learning Objective: 1. Describe the ways in which adequate LN dissection improves long-term survival without compromising patient safety. Background. The present study assessed the impact of the retrieval of >25 lymph nodes (LNs) on the survival outcome of patients with advanced gastric cancer after curative‐intent gastrectomy. Patients and Methods. A total of 5,386 patients who had undergone curative gastrectomy for gastric cancer from 1994 to 2011 were enrolled. The clinicopatholo...
Society For Translational Oncology

Precision Medicine and Impact of Therapeutic Drug Levels

Much has been written recently about the need for genetic testing and biomarkers to identify specific targets within cancers, recognizing that there are many subclones and individual differences within the malignancies that arise in patients, even in those with morphologically similar cancers. Another important aspect of cancer treatment is the need to optimize the dose and schedule of administered therapies. Pharmacogenomics has demonstrated that the bioavailability and half-lives of anti-ca...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeting EGFR, T790M, ALK, and ROS1 in NSCLC

Oncology treatment teams are tasked with navigating through a steady increase in the number and complexity of molecular biomarkers that guide treatment decisions. FDA-approved companion tests have expanded testing options and provide uniformity of reporting, yet challenges in the clinical setting and the potential to negatively impact patient outcomes persist. As part of the continuum of care in oncology, there is an increasing demand for genomic testing to guide the course of treatment. Misi...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

The Oncologist: The Impact of an Educational Program on Patient Practices for Safe Use, Storage, and Disposal of Opioids at a Comprehensive Cancer Center

Learning Objectives: 1. Describe the problem of opioid abuse as it relates to knowledge of patients regarding proper use, storage, and disposal of opioids. 2. Describe the process undergone by the outpatient supportive care clinic described in the article to implement an opioid education program in order to address gaps in patient knowledge. Background. Improper use, storage, and disposal of prescribed opioids can lead to diversion or accidental poisoning. Our previous study showed a lar...
Society For Translational Oncology

The Oncologist: A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer – Alliance (CALGB) 9581 and 89803

Learning Objectives: 1. Describe the association between tumor levels of thymidylate synthase and outcomes in patients with resected colon cancer treated with adjuvant therapy 2. Discuss the value of thymidylate synthase levels in predicting treatment benefits of 5-fluorouracil in patients with resected colon cancer Purpose. Tumor levels of thymidylate synthase (TS), a target of 5‐fluorouracil (5‐FU)‐based chemotherapy for colorectal cancer, have been studied as a predictive or pro...
Society For Translational Oncology

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing over the past 3 months.
Slack Inc.

Penn Radiology Oncologic Imaging: Optimizing Patient Care (Streaming Online & DVD-ROM)

Penn Radiology joins forces with its experts in Nuclear Medicine, Gastroenterology, Pulmonology, Radiation and Interventional Oncology to present this comprehensive review of Oncologic Imaging. Best practices and clinical correlates will be discussed, with two detailed sessions dedicated to CT screening for lung cancer. Credits for this program can be applied toward your Self Assessment CME Requirements for ABR Maintenance of Certification. Topics: CT Screening for Lung Cancer, State of th...
Meetings By Mail®

Penn Radiology Oncologic Imaging: Optimizing Patient Care

Meetings by Mail presents Penn Radiology Oncologic Imaging: Optimizing Patient Care. This comprehensive review of Oncologic Imaging features discussions regarding best practices and clinical correlates, with two detailed sessions dedicated to CT screening for lung cancer.  Other topics include: state of the art and emerging techniques, head and neck cancer, thoracic, GI and other abdominal Malignancies, neuroendocrine tumors, lymphoma, melanoma and MSK. Available in Online Streaming and DVD...
Meetings by Mail

4th Annual Ash 2018 Updates: Practice Changing Abstracts

Patients in medically underserved communities have limited access to subspecialty care. Community-based oncologists are well positioned to provide initial care for these patients, but often do not have the knowledge and confidence to manage difficult cases. According to the 2015 Community Health Needs Assessment, between 2006 and 2008, the City of Chicago experienced an annual average adjusted cancer mortality rate of 194.2 deaths per 100,000 individuals. Cancer mortality has decreased over th...
Meeting Achievement

Clinical and Multidisciplinary Hematology and Oncology 2019 : The 16th Annual Review

This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on hematologic diseases, solid tumors and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues involved with the care of patients.
Mayo Clinic

NYU's Head to Toe Imaging: NYU School of Medicine Clinical Update

Topics covered by NYU's Head to Toe Imaging include: Imaging of Pancreatic Adenocarcinoma, Inflammatory Bowel Disease, Renal Cell Carcinoma, Abdominal Trauma, Thyroid Ultrasound, Airway Disease, Coronary Artery Disease, Chest Imaging, Brain Tumor, Pediatric Abdomen. Pediatric Knee, Cruciate Ligaments, Posterior Shoulder Instability, Venous Thromboembolism and many others. After viewing NYU's Head to Toe Imaging, you will be better able to: • Evaluate and incorporate current imaging techni...
CMEInfo

Metastatic Breast Cancer

While mortality rates for breast cancer are decreasing, metastatic breast cancer (MBC) remains incurable. This session will review new treatment options based on molecular and genetic information, the level of evidence used to formulate practice guidelines, as well as updates from ASCO 2017. New agents, including PARP inhibitors for those with appropriate mutations, will also be discussed. Clinically-oriented guidelines on the management of MBC were developed by the European Society for Medica...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Redefining Care for BRCA and Other Familial-associated Cancers

Advances in molecular genetics and testing have refined the diagnosis, treatment, and follow-up for patients with BRCA and other familial genetic syndromes. As women with germline BRCA1 and BRCA2 mutations are at an increased risk for developing high-grade serous ovarian cancer, there are implications for genetic testing, family counseling, radiologic screening, and pharmaceutical choices in the community setting. Molecular and genetic advances, such as novel PARP inhibitors, are altering the ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new therapies are associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatologists are likely to encounter a wide variety of irAEs as the use of immune checkpoint inhibitors expands in the treatment of several cancers. Thus, it is critical for rheumatologists to be aware of these complications to accurately ...
Slack Inc.

Interventional Pulmonology in Cancer Patients

www.mdanderson.org/conferences
MD Anderson

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However, immunotherapy with PD-1/PD-L1 checkpoint inhibitors is revolutionizing the treatment of bladder cancer. Currently, 5 checkpoint inhibitors are approved for patients who have failed prior platinum-based chemotherapy or are ineligible for cisplatin-based chemotherapy. In this CME activity, expert faculty will assess the clinical evidence regarding the efficacy, safety, and tolerability...
Slack Inc.

Fact or Fiction? Sorting Out Common Misconceptions About Ulcerative Colitis to Improve Patient Care

It is well established that ulcerative colitis (UC) is a heterogeneous disease with symptoms that wane over time. The disease course for 50% of individuals is persistently active over time with worsening and relapsing symptoms and is associated with long-term anemia, colonic dysfunction, and increased risk for colorectal cancer. Evidence indicates that treating the inflammation to achieve improvement in endoscopic appearance of the mucosa early in the course of UC is effective for current flar...
CME Outfitters

Use of Oncology Quality Measures Where Do We Go from Here?

The new CMMI guidelines for physician reimbursement for patient care require some demonstration of quality and value in care delivery. Certain quality programs are available to oncologists (such as PQRS, QOPI, etc.). These assessments of quality require demonstration that specific guidelines are measured and followed within acceptable compliance targets. This session will address how these measures are developed and applied for use in the new payment models.
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Achieving Precision Care in Gastrointestinal Cancers

Treatment selection is largely dependent on the goals of therapy; however, sequencing of standard therapies with newly approved therapies as patients’ progress is a key factor in improving quality of care. The recent approval of new agents and advances in biomarker detection have supported the individualization of treatment and subsequent improvements in survival for patients with gastrointestinal cancers. As new agents are expected to enter the treatment paradigm in 2017, clinicians will r...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Practical Thoracic Imaging 2019

PRACTICAL THORACIC IMAGING course is designed as a comprehensive imaging review of diseases that affect the chest. Experienced faculty has been selected to cover the subject material that emphasizes their approach to solving clinically relevant problems involving the chest. Review of traditional imaging as well as the benefits and caveats of newer imaging techniques will be presented. Ample time for questions and discussion will be provided. There will be practical case presentations to enco...
iiCME

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

The recent inclusion of targeted biologic agents in guideline recommendations has provided oncologists with more treatment options and patients with the potential for improved outcomes. However, these additional options also increase the complexity of treatment selections and appropriate sequencing of treatments for patients with gastric and gastroesophageal (GEJ) cancers. Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer will guide community clinicians...
The Potomac Center for Medical Education

Advances in Colorectal Cancer – From Screening to Innovative Care

Colorectal cancer is the #2 cause of cancer death in North America. While we successfully screen for colorectal cancer, many gaps in evidence-based treatment remain. Current practitioners have questions about the role of circulating tumor DNA in the diagnosis and management of early to advanced colorectal cancer; the role of endoscopic microsurgery in the management of colon cancer; and when full oncologic surgery is required to deliver the most appropriate care for colon cancer. For patients ...
Virginia Mason

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman with a myeloproliferative disorder. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

The Oncologist: Aspirin is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction

Learning Objectives: 1. Describe the relationship between severe thrombocytopenia and mortality in patients with AMI and hematologic malignancies. 2. Discuss the effect of aspirin therapy on patients with AMI and severe thrombocytopenia. Background. Patients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin are not known in thrombocytopenic cancer patients experiencing acute myocardial infarction (AMI). Materials and Methods. ...
Society For Translational Oncology

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Patients with radioactive iodine-refractory thyroid cancer (RAIR-DTC) have poor prognoses and, until recently, there were no effective targeted systemic therapies available for RAIR-DTC. Targeted therapies sorafenib and lenvatinib have been approved by the FDA for treating RAIR-DTC in the last 5 years. Along with these approved therapies, other targeted therapies, such as cabozantinib and vandetanib, which were approved earlier in the decade by the FDA for treating medullary thyroid cancer, ar...
The Endocrine Society, Rockpointe Oncology

DSM-5 and ICD-10: Uses, Challenges, and Documentation

Explore DSM-5 Coding issues, uses and misuses in the world of ICD-10. Dr. Peck will define the clinical dilemmas in the use of DSM-5 or ICD-10 and the important changes Psychologists need to know in certain clinical diagnoses. Examine clinical documentation improvement efforts in transitioning to ICD-10. MHMD Memorial Hermann’s journey to improve documentation and coding. At the conclusion of the activity, attendees will be able to: Explain the correlation of DSM-5 and ICD coding as...
American Board of Quality Assurance and Utilization Review Physicians (ABQAURP)

Breast Imaging 2019

This course blends the newest innovations in breast imaging with time-honored traditional breast imaging modalities and procedures. Special attention will be given to Tomosynthesis and Breast MR, as well as Whole Breast Ultrasound. The contentious issues of Breast Density Legislation and Screening Guidelines will also be addressed. An interactive screening workshop in which the participants can evaluate 25 digital screening cases WITH TOMOSYNTHESIS at the workstation will be available in th...
iiCME

Quality Management and Compliance in the Pharmaceutical and Related Industries

Who Should Attend? This intensive course will benefit those who need to understand the responsibilities and functions of the Quality Unit in a pharmaceutical firm and how the quality organization impacts all areas of operations and works as a team to help assure the quality of the products and compliance to regulations within in the pharmaceutical manufacturing arenas and related products. This material is particularly suitable for chemists, pharmacists, engineers and administrators working i...
CfPA

Optimizing Patient Outcomes in Castration-Resistant Prostate Cancer: Moving Urologists From Knowledge to Action

Evan Ya-Wen Yu, MD, provides his insights into the evolving management of patients with castration-resistant prostate cancer (CRPC) and the implications of the genomic landscape on CRPC. Since clinical trial evidence does not clearly inform sequencing strategies, Dr. Yu weaves his insight into this conundrum using 3 cases, with suggestions to help the urologist individualize treatment. CONTENT AREAS • National Comprehensive Cancer Network guidelines on prostate cancer • Clinical tria...
Annenberg Center for Health Sciences at Eisenhower

Lung Cancer Imaging: World Class CME and Oakstone Clinical Update

Topics covered by Lung Cancer Imaging include: Lung Cancer Screening, Lung Nodule Classification, Repeat Annual Screens, Lung Cancer Diagnosis, Smoking Related Diffuse Lung Diseases, Imaging the Adenocarcinoma Spectrum, Lung Cancer Treatment, Imaging the Post-Surgical Lung Cancer Patient and many others. Lung Cancer Imaging covers best practices in interpreting CT scans obtained for lung cancer screening, staging, and treatment follow-up for those who may be actively involved in lung cancer ...
CMEInfo

Obstetrics and Gynecology 2019

New Diagnosis and Treatment Updates in Clinical Obstetrics, Minimally Invasive Gynecologic Surgery, Urogynecology, Gynecologic Oncology, Reproductive Endocrinology, and Infertility This special update on diagnosis and treatment of reproductive health conditions in women, designed and presented by Harvard Medical School’s leading faculty and master clinicians, ensures you are current with the latest advances in obstetrics and gynecology. One of the highest-rated Harvard Medical School CME ...
Harvard Medical School

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.